Novo Biosciences
Innovative cardiac treatments reviving the body's own healing powers to regenerate heart tissue and improve lives.
Innovative cardiac treatments reviving the body's own healing powers to regenerate heart tissue and improve lives.
Novo Biosciences is a biotechnology startup that is dedicated to developing innovative cardiac treatments geared towards reversing the life-threatening damage caused by heart attacks. Their approach involves reviving the body's own healing powers to regenerate heart tissue and improve lives. The company's treatments are designed to activate powerful mechanisms of self-repair and regrowth within dormant genes, allowing patients to regenerate damaged organs and tissues for better overall health. Founded in 2013 and headquartered in Bar Harbor, Maine, Novo Biosciences secured a significant $4.00M Venture Round investment on 28 May 2020. Novo Biosciences operates at the intersection of Biotechnology, Health Care, and Health and Wellness, positioning itself at the forefront of innovative solutions in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $4.00M | - | 28 May 2020 | |
| Grant | $50.00K | 1 |
|
01 Jan 2020 |
| Grant | $1.50M | 1 | National Institutes of Health | 07 Sep 2017 |
| Grant | $25.00K | 1 |
|
22 Jul 2014 |
| Grant | $25.00K | 1 |
|
20 Aug 2013 |
No recent news or press coverage available for Novo Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
